Douglas K. Bratton serves as Executive at Juno Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Douglas K. Bratton has executed 14 insider transactions totaling $181.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 12, 2021 involved selling 2,216,798 shares valued at $144.1M.
Douglas K. Bratton currently holds 9,984,836 shares of Juno Therapeutics, Inc. (JUNO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas K. Bratton has been a net seller of JUNO stock. They have purchased $15.0M and sold $166.4M worth of shares.
Douglas K. Bratton's most recent insider trade was on Feb 12, 2021, when they sold 2,216,798 shares at $65.00 per share.
Get notified when new Form 4 filings are submitted
| $25.69 |
| Discretionary |
| Jun 23, 2020 | DNLI | $85.0K | Sale | 3,247 | $26.19 | Discretionary |
| Jun 22, 2020 | DNLI | $1.6M | Sale | 65,373 | $24.66 | Discretionary |
| Jun 22, 2020 | DNLI | $620.0K | Sale | 24,683 | $25.12 | Discretionary |
| Jun 19, 2020 | DNLI | $1.6M | Sale | 62,439 | $25.00 | Discretionary |
| Jun 19, 2020 | DNLI | $2.0M | Sale | 82,481 | $24.20 | Discretionary |
| Jul 2, 2015 | JUNO | $2.2M | Sale | 40,000 | $54.75 | Discretionary |
| Jun 24, 2015 | JUNO | $6.9M | Sale | 135,000 | $51.33 | Discretionary |
| Jun 23, 2015 | JUNO | $0 | Other | 825,726 | $N/A | Discretionary |
| Jun 23, 2015 | JUNO | $6.9M | Sale | 135,000 | $50.92 | Discretionary |
| Dec 23, 2014 | JUNO | $0 | Conversion | 1,250,000 | $N/A | Discretionary |
| Dec 23, 2014 | JUNO | $0 | Conversion | 68,395 | $N/A | Discretionary |
| Dec 23, 2014 | JUNO | $15.0M | Purchase | 625,000 | $24.00 | Discretionary |